You are here

Cennerv Pharma aims to raise US$40m for groundbreaking drugs

The biotech venture is ramping up efforts to bring to market drugs that can treat mental disorders

Dr Ratty (right) has founded three biotech companies and now runs Cennerv Pharma with chief scientific officer Michael Entzeroth (left), former deputy director of the A*Star Experimental Therapeutics Centre


WHEN Anil K Ratty first endeavoured to use science to improve humankind, he had no idea of the massiveness of his task. Some 15 years later, the Singapore neuroscientist-turned-bioentrepreneur - amid developing drugs to treat mental disorders - now wants to attempt a new